132 related articles for article (PubMed ID: 8892958)
21. No evidence of vertical transmission of naturally acquired feline immunodeficiency virus infection.
Ueland K; Nesse LL
Vet Immunol Immunopathol; 1992 Sep; 33(4):301-8. PubMed ID: 1332250
[TBL] [Abstract][Full Text] [Related]
22. Involvement of cytolytic and non-cytolytic T cells in the control of feline immunodeficiency virus infection.
Flynn JN; Dunham S; Mueller A; Cannon C; Jarrett O
Vet Immunol Immunopathol; 2002 Mar; 85(3-4):159-70. PubMed ID: 11943317
[TBL] [Abstract][Full Text] [Related]
23. Protection of neonatal kittens against feline immunodeficiency virus infection with passive maternal antiviral antibodies.
Pu R; Okada S; Little ER; Xu B; Stoffs WV; Yamamoto JK
AIDS; 1995 Mar; 9(3):235-42. PubMed ID: 7755911
[TBL] [Abstract][Full Text] [Related]
24. Peptide mapping of feline immunodeficiency virus by IFN-gamma ELISPOT.
Dean GA; LaVoy A; Burkhard MJ
Vet Immunol Immunopathol; 2004 Jul; 100(1-2):49-59. PubMed ID: 15182995
[TBL] [Abstract][Full Text] [Related]
25. Envelope gene-mediated neurovirulence in feline immunodeficiency virus infection: induction of matrix metalloproteinases and neuronal injury.
Johnston JB; Silva C; Power C
J Virol; 2002 Mar; 76(6):2622-33. PubMed ID: 11861828
[TBL] [Abstract][Full Text] [Related]
26. 16alpha-Bromo-epiandrosterone therapy modulates experimental feline immunodeficiency virus viremia: initial enhancement leading to long-term suppression.
Pedersen NC; North TW; Rigg R; Reading C; Higgins J; Leutenegger C; Henderson GL
Vet Immunol Immunopathol; 2003 Aug; 94(3-4):133-48. PubMed ID: 12909410
[TBL] [Abstract][Full Text] [Related]
27. Feline immunodeficiency virus subunit vaccines that induce virus neutralising antibodies but no protection against challenge infection.
Huisman W; Karlas JA; Siebelink KH; Huisman RC; de Ronde A; Francis MJ; Rimmelzwaan GF; Osterhaus AD
Vaccine; 1998; 16(2-3):181-7. PubMed ID: 9607028
[TBL] [Abstract][Full Text] [Related]
28. Lentivirus infection in the brain induces matrix metalloproteinase expression: role of envelope diversity.
Johnston JB; Jiang Y; van Marle G; Mayne MB; Ni W; Holden J; McArthur JC; Power C
J Virol; 2000 Aug; 74(16):7211-20. PubMed ID: 10906175
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous mycoflora and CD4:CD8 ratio of cats infected with feline immunodeficiency virus.
Reche A; Daniel AG; Lazaro Strauss TC; Taborda CP; Vieira Marques SA; Haipek K; Oliveira LJ; Monteiro JM; Kfoury JR
J Feline Med Surg; 2010 Apr; 12(4):355-8. PubMed ID: 20156698
[TBL] [Abstract][Full Text] [Related]
30. Mucosally transmitted feline immunodeficiency virus induces a CD8+ antiviral response that correlates with reduction of cell-associated virus.
Bucci JG; English RV; Jordan HL; Childers TA; Tompkins MB; Tompkins WA
J Infect Dis; 1998 Jan; 177(1):18-25. PubMed ID: 9419165
[TBL] [Abstract][Full Text] [Related]
31. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
[TBL] [Abstract][Full Text] [Related]
32. Effects of incidental infections and immune activation on disease progression in experimentally feline immunodeficiency virus-infected cats.
Reubel GH; Dean GA; George JW; Barlough JE; Pedersen NC
J Acquir Immune Defic Syndr (1988); 1994 Oct; 7(10):1003-15. PubMed ID: 7916048
[TBL] [Abstract][Full Text] [Related]
33. Interaction of acute feline herpesvirus-1 and chronic feline immunodeficiency virus infections in experimentally infected specific pathogen free cats.
Reubel GH; George JW; Barlough JE; Higgins J; Grant CK; Pedersen NC
Vet Immunol Immunopathol; 1992 Dec; 35(1-2):95-119. PubMed ID: 1363011
[TBL] [Abstract][Full Text] [Related]
34. Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus.
Burkhard MJ; Obert LA; O'Neil LL; Diehl LJ; Hoover EA
AIDS Res Hum Retroviruses; 1997 Mar; 13(4):347-55. PubMed ID: 9071435
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic utility of CD4%:CD8 low% T-lymphocyte ratio to differentiate feline immunodeficiency virus (FIV)-infected from FIV-vaccinated cats.
Litster A; Lin JM; Nichols J; Weng HY
Vet Microbiol; 2014 Jun; 170(3-4):197-205. PubMed ID: 24559863
[TBL] [Abstract][Full Text] [Related]
36. Early events in the immunopathogenesis of feline retrovirus infections.
Tompkins MB; Nelson PD; English RV; Novotney C
J Am Vet Med Assoc; 1991 Nov; 199(10):1311-5. PubMed ID: 1666073
[TBL] [Abstract][Full Text] [Related]
37. Productive infection of the bone marrow cells in feline immunodeficiency virus infected cats.
Sandy JR; Robinson WF; Bredhauer B; Kyaw-Tanner M; Howlett CR
Arch Virol; 2002 May; 147(5):1053-9. PubMed ID: 12021873
[TBL] [Abstract][Full Text] [Related]
38. Effect of chronic feline immunodeficiency virus infection on experimental feline calicivirus-induced disease.
Reubel GH; George JW; Higgins J; Pedersen NC
Vet Microbiol; 1994 Apr; 39(3-4):335-51. PubMed ID: 8042279
[TBL] [Abstract][Full Text] [Related]
39. T-lymphocyte profiles in FIV-infected wild lions and pumas reveal CD4 depletion.
Roelke ME; Pecon-Slattery J; Taylor S; Citino S; Brown E; Packer C; Vandewoude S; O'Brien SJ
J Wildl Dis; 2006 Apr; 42(2):234-48. PubMed ID: 16870846
[TBL] [Abstract][Full Text] [Related]
40. Efficacy evaluation of prime-boost protocol: canarypoxvirus-based feline immunodeficiency virus (FIV) vaccine and inactivated FIV-infected cell vaccine against heterologous FIV challenge in cats.
Tellier MC; Pu R; Pollock D; Vitsky A; Tartaglia J; Paoletti E; Yamamoto JK
AIDS; 1998 Jan; 12(1):11-8. PubMed ID: 9456250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
